Compare Enveric Biosciences Inc (ENVB) vs NEOS S&P 500 High Income ETF (SPYI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs NEOS S&P 500 High Income ETF — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while NEOS S&P 500 High Income ETF trades at $53.66. The key difference: NEOS S&P 500 High Income ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SPYI | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $17.40 | $54.07 |
52-Week Low | $1.28 | $47.98 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPYI trades at $53.56, up 0.36% with a bullish technical outlook supported by moving averages. The ETF has surpassed $10 billion in assets under management (24/7 Wall Street, July 2026) and maintains consistent monthly distributions through its covered call strategy. Recent dividend payments of $0.52-$0.54 demonstrate stable income generation, though key valuation ratios remain undisclosed.
The fund's dual-option strategy provides downside protection while capturing partial upside, making it attractive for income-focused investors. Risks include potential return of capital distributions and competition from similar income ETFs. Institutional interest remains strong as retirees shift from traditional bonds to high-yield alternatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About NEOS S&P 500 High Income ETF
SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →
